Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305799200 on June 16, 2003

J. Biol. Chem., Vol. 278, Issue 36, 33645-33653, September 5, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/33645    most recent
M305799200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schröder, N. W. J.
Right arrow Articles by Schumann, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schröder, N. W. J.
Right arrow Articles by Schumann, R. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Acylated Cholesteryl Galactoside as a Novel Immunogenic Motif in Borrelia burgdorferi Sensu Stricto*

Nicolas W. J. Schröder {ddagger}, Ursula Schombel §, Holger Heine ¶, Ulf B. Göbel {ddagger}, Ulrich Zähringer § and Ralf R. Schumann {ddagger} ||

From the {ddagger}Institut für Mikrobiologie und Hygiene, Universitätsklinikum "Charité," Medizinische Fakultät der Humboldt-Universität zu Berlin, Dorotheenstrasse 96, D-10117 Berlin, Germany and the §Division of Immunochemistry and Junior Research Group Innate Immunity, Research Center Borstel, Liebniz Center for Medicine and Biosciences, Parkallee 22, D-23845 Borstel, Germany

Borrelia burgdorferi sensu lato is the causing agent of Lyme disease, an infectious disease frequently occurring in the United States, Europe, and Northern Asia. Currently, diagnosis of and vaccination strategies against this pathogen are exclusively based on proteinaceous structures. Here we report on a novel class of immunogenic glycolipids purified from B. burgdorferi sensu stricto B31. Employing a butanol/water extraction procedure with subsequent Bligh/Dyer extraction of the organic phase, thin layer chromatography analysis revealed the presence of three distinct glycolipids, which were chemically analyzed employing combined gas-liquid chromatography/mass spectroscopy, matrix-assisted laser desorption/ionization mass spectrometry, and NMR. We identified acylated cholesteryl galactoside (ACG) next to cholesteryl galactoside and {alpha}-monogalactosyl-diacylglycerol. After extensive purification, the glycolipids investigated failed to cause proinflammatory responses in human cells transfected with human toll-like receptor (TLR)-2 or -4. However, we observed a marked recognition of ACG by sera derived from patients suffering from Lyme disease. These data indicate that newly described ACG is involved in developing host immunity during Lyme disease and thus may be useful for diagnosis and vaccination.


Received for publication, June 3, 2003 , and in revised form, June 16, 2003.

Note Added in Proof—During the review process of this manuscript, an article has appeared confirming the chemical part of our findings (Ben-Menachem, G., Kubler-Kielb, J., Coxon, B., Yergey, A., and Schnerson, R. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 7913–7918).

* This work was supported in part by Deutsche Forschungsgemeinschaft Grants Schr 726/1-1 (to R. R. S. and N. W. J. S.), ZA 149/5-1 (to U. Z.), and He 2758/3-1 (to H. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence and reprint requests should be addressed. Tel.: 49-30-450-524141; Fax: 49-30-450-524904; E-mail: ralf.schumann{at}charite.de.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. Stubs, V. Fingerle, B. Wilske, U. B. Gobel, U. Zahringer, R. R. Schumann, and N. W. J. Schroder
Acylated Cholesteryl Galactosides Are Specific Antigens of Borrelia Causing Lyme Disease and Frequently Induce Antibodies in Late Stages of Disease
J. Biol. Chem., May 15, 2009; 284(20): 13326 - 13334.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Tupin, M. R.-E.-I. Benhnia, Y. Kinjo, R. Patsey, C. J. Lena, M. C. Haller, M. J. Caimano, M. Imamura, C.-H. Wong, S. Crotty, et al.
NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi
PNAS, December 16, 2008; 105(50): 19863 - 19868.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-H. Lebrun, C. Wunder, J. Hildebrand, Y. Churin, U. Zahringer, B. Lindner, T. F. Meyer, E. Heinz, and D. Warnecke
Cloning of a Cholesterol-{alpha}-glucosyltransferase from Helicobacter pylori
J. Biol. Chem., September 22, 2006; 281(38): 27765 - 27772.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement